Clinical reference Biomarker Directory
Back to directory

Anti-ribosomal P antibodies

Established

Anti-Rib-P is a specific but insensitive marker for neuropsychiatric lupus, especially psychosis.

Also known as Anti-Rib-P anti-P antibody
In plain language

This antibody is linked to lupus affecting the brain, especially causing psychosis or mood problems. A positive test is a strong clue, but a negative one doesn't rule out brain involvement, and there's no single standard lab test for it yet.

Biomarker & context

Anti-ribosomal P protein antibodies (anti-Rib-P) target phosphorylated ribosomal proteins and are a highly specific, though not highly sensitive, marker associated with lupus, particularly its neuropsychiatric manifestations.

What it indicates

Anti-Rib-P is most strongly linked to lupus psychosis and mood disorders among neuropsychiatric SLE presentations; it is specific for psychosis but not sensitive, meaning its absence does not rule out neuropsychiatric lupus.

Diagnosis & clinical testing

Measured via ELISA or immunoblot; no standardized commercial assay currently exists, which affects reproducibility across laboratories. Prevalence varies markedly by ethnicity, ranging from about 6-20% in most populations to as high as 36% reported in some Chinese SLE cohorts.

Guiding treatment

A positive anti-Rib-P in a lupus patient with new psychiatric symptoms supports attributing those symptoms to neuropsychiatric lupus rather than an unrelated psychiatric illness, which can influence the choice of immunosuppressive versus purely psychiatric treatment.

Clinical significance

No standardized assay exists; prevalence and clinical association vary notably by ethnicity.

References
  1. Toubi, E., & Shoenfeld, Y. (2007). Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmunity Reviews.
  2. Karassa, F. B., et al. (2006). Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric SLE. Arthritis & Rheumatism.